MoneyWorks4Me

Shamrock Indl. Co - Quaterly Results

10 Aug 2023 Evaluate
A minor change in the total revenue was seen in the June 2023 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Net Loss for the quarter ended June 2023 is Rs. -0.59 millions as compared to Net Loss of Rs. -0.46 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 further decreased to -0.59% as compared to -0.46% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.97 0.00
PBIDT -0.59 -0.46 28.26 -0.59 -0.46 28.26 -1.28 -2.07 -38.16
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.59 -0.46 28.26 -0.59 -0.46 28.26 -1.28 -2.07 -38.16
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.59 -0.46 28.26 -0.59 -0.46 28.26 -1.28 -2.07 -38.16
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.59 -0.46 28.26 -0.59 -0.46 28.26 -1.29 -2.07 -37.68
Equity 54.28 54.28 0.00 54.28 54.28 0.00 54.28 54.28 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..